Argenx
ARGX
#523
Rank
A$62.25 B
Marketcap
$997.95
Share price
-0.33%
Change (1 day)
67.08%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2023 (TTM): -$6.30

According to Argenx 's latest financial reports the company's current EPS (TTM) is -$6.67. In 2022 the company made an earnings per share (EPS) of -$21.03.

EPS history for Argenx from 2022 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$6.30-70.04%
2022-$21.03